• Profile
Close

Targeting pathway may reduce cocaine's cardiovascular harms

American Heart Association News Feb 28, 2018

Scientists have discovered a potential new pathway to treat the harmful effect of cocaine on the cardiovascular system, according to new research in the American Heart Association’s journal Hypertension.

Researchers found that excess levels of reactive oxygen species (ROS), molecules known to be found in the aortas of hypertensive animals and humans, are also involved in cocaine-related cardiovascular disease. ROS is a type of unstable molecule that contains oxygen and that easily reacts with other molecules in a cell. A buildup of ROS in cells may cause damage to DNA, RNA, and proteins and may cause cell death.

The team determined that cocaine activates the molecule microRNA (miR-30c-5p), increasing ROS levels in the cardiovascular system. But, blocking activation of miR-30c-5p dramatically reduced cocaine-induced cardiovascular impacts.

“The biggest surprise to us was that the modulation of a single miRNA-mRNA pathway could have such a profound effect on cardiovascular function,” says Chunming Dong, MD, study senior author and professor of medicine at University of Miami School of Medicine. “This also suggests that targeting this one pathway may have significant therapeutic benefit, which is an exciting possibility.”

In the study, mice injected with cocaine had high blood pressure, stiff blood vessels, and excess levels of ROS—all indications of cardiovascular disease. Cocaine exposure also increased levels of the miR-30c-5p molecule in the mice. When the researchers treated the mice to block the increase in miR-30c-5p, the mice did not show high blood pressure, stiffer blood vessels, or elevated ROS levels when given cocaine.

This study is the first to identify the role of miR-30c-5p in cocaine-related cardiovascular disease, Dong says. While the results are promising, the study has limitations as it was conducted in mice, Dong notes. The team plans to test the findings to see if they are observed in patients to determine the viability of this targeted pathway.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay